Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers

Journal of Hypertension

Volumn 16, Issue 2, 1998, Pages 245-250

  Vervoort, Gerald ^a   Hertenberg, Frank ^a   Wetzels, Jack F ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Albuminuria; Angiotensin converting enzyme inhibition; Angiotensin II type 1 receptor antagonism; Atrial natriuretic factor; Blood pressure; Natriuresis

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIURESIS; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NATRIURESIS; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; TIME;

EID: 0031907229     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816020-00016     Document Type: Article

References (27)

1. Ballermann BJ, Brenner BM. Role of atrial peptides in body fluid homeostasis. Circ Res 1986; 58:619-630.
2. Marin-Grez A, Flemming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilation and post-glomerular vasoconstriction in rat kidney. Nature 1986; 324:473-476.
3. Gaillard CA, Koomans HA, Rabelink TJ, Boer P, Dorhout Mees EJ. Opposite effects of enalapril and nitrendipine on natriuretic response to atrial natriuretic factor. Hypertension 1989; 13:173-180.
4. Gaillard CA, Koomans HA, Dorhout Mees EJ. Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension 1988; 11:160-165.
5. Wilkins MR, Lewis HM, West MJ, Kendall MJ, Lote CJ. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives. J Hum Hypertens 1987; 1:47-51.
6. Wambach G, Schittenhelm U, Stimpel M, Bönner G, Kaufmann W. Natriuretic action of ANP is blunted by ACE inhibition in humans. J Cardiovasc Pharmacol 1989; 13:748-753.
7. McMurray J, Seidelin P, Howey J, Balfour D, Struthers A. The effect of atrial natriuretic factor on urinary albumin and β2-microglobulin excretion in man. J Hypertens 1988; 6:783-786.
8. Johnston CI. Angiotensin receptor antagonists: focus on losartan. Lancet 1995; 346:1403-1407.
9. Richards AM, Rao G, Espiner EA, Yandle T. Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor. Hypertension 1989; 13:193-199.
10. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 1994; 24:112-129.
11. Veress AT, Chong CK, Honrath U, Sonnenberg H. Effect of bradykinin B2 receptor antagonist and indomethacin on natriuretic and hypotensive responses to atrial natriuretic factor. Can J Physiol Pharmacol 1994; 72:1561-1566.
12. + transport. Kidney Int 1993; 43:1236-1242.
13. Abassi ZA, Klein H, Cox J, Keiser HR. Bradykinin does not modulate the natriuretic response to atrial natriuretic factor in rats with aortocaval fistula. Hypertension 1993; 21:966-970.
14. Trippodo NC, MacPhee AA, Cole FE. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin. J Hypertens 1984, 2 (suppl 3):S289-S291.
15. Semmekrot B, Theelen B, Monnens L. Evidence for a proximal site of action of atrial natriuretic peptide in man. Child Nephrol Urol 1990; 10:32-38.
16. Eiskjær H, Mogensen CE, Schmitz A, Pedersen EB. Enhanced urinary excretion of albumin and β2 microglobulin in essential hypertension induced by atrial natriuretic peptide. Scand J Clin Lab Invest 1991; 51:359-366.
17. Sawicki PT, Heinemann L, Rave K, Hohmann A, Berger M. Atrial natriuretic factor in various stages of diabetic nephropathy. J Diab Compl 1988; 2:207-209.
18. Bell GM, Bernstein RK, Laragh JH, Atlas SA, James GD, Pecker MS, et al. Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci 1989; 77:177-182.
19. Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats; potential mediator of hyperfiltration. J Clin Invest 1987; 80:670-674.
20. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329:1456-1462.
21. Parving H-H, Hommel E, Nielsen MD, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. BMJ 1989; 299:533-536.
22. Gansevoort R, de Zeeuw D, de Jong PE. Is the antiproteinuric effect of ACE-inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994; 45:861-867.
23. Mayer G, Lafayette RA, Oliver J, Deen WM, Myers BD, Meyer TW. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Kidney Int 1993; 43:346-353.
24. Lanese DM, Yuan BH, Falk SA, Conger JD. Effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am J Physiol 1991; 261:F1102-F1109.
25. Elving LD, Wetzels JFM, de Nobel E, Hoitsma AJ, Berden JHM. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy. Am J Kidney Dis 1992; 6:559-563.
26. Morelli E, Loon N, Meyer TW, Peters W, Myers BD. Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39:76-82.
27. Tanaka R, Kon V, Yoshioko T, Ichikawa I, Fogo A. Angiotensin converting enzyme inhibition modulates glomerular function and structure by distinct mechanisms. Kidney Int 1994; 45:537-543.